Although the combination of several antibodies, including CD99, EMA, and S100, has been proposed for diagnosing SS using immunohistochemistry (IHC), it is difficult to obtain the correct diagnosis due to overlap with other benign and malignant tumors [6]. This evidence concerns the gene CD99 and synovial sarcoma.